Several elements of the Inflation Reduction Act (IRA) align with CMS’ goals of promoting equity through health policy, explained A. Mark Fendrick, MD, co–editor in chief of The American Journal of Managed Care® and director of the V-BID Center at the University of Michigan.
Several elements of the Inflation Reduction Act (IRA) align with CMS’ goals of promoting equity through health policy, explained A. Mark Fendrick, MD, co–editor in chief of The American Journal of Managed Care® and director of the V-BID Center at the University of Michigan.
Transcript
How will the elements of the IRA mesh with CMS’ efforts to overhaul payment models with an eye toward ensuring health equity?
Having worked in the area of equity enhancement and disparity reduction for 30 years, I'm extremely pleased to see the attention that this administration and this law in particular pays to enhancing equity. Specifically around the area of access and affordability, we've shown quite clearly that if you make people pay more for something, they'll buy less of it. And there's no surprise that the burden of out-of-pocket costs falls disproportionately on populations of color, those with multiple chronic conditions, and those who are financially insecure. So any policies such as an out-of-pocket cap for Medicare Part D, a decrease in out-of-pocket costs for D-rated vaccines, or broader issues that are included in this bill regarding access and affordability will hopefully lead to disproportionate benefit of these same populations of color and financial insecurity to benefit that. So I'm cautiously optimistic that many of these policies will make a small step forward regarding equity enhancement, and we're hopeful that these will mesh nicely with other CMS and CMMI initiatives to put equity enhancement first.
Reduced Rehospitalizations and Potential Cost Savings With Orca-T for Acute Leukemia, MDS
April 11th 2025Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
National Data Show Rising Risk, Cost of CKD in Patients With Acute Myocardial Infarction
April 10th 2025A series of new studies from the National Kidney Foundation Spring Clinical Meeting exhibit the association between impaired kidney function and prolonged hospital stays, higher charges, and greater resource utilization.
Read More
Collaborative Care Model Offers Success in Reducing Suicide Risk, New Report Finds
April 10th 2025A report published today by Shatterproof and The Bowman Family Foundation underscores the potential of the collaborative care model to lower suicide risk across diverse patient populations and health systems.
Read More